|
Prescriptions continue to raise concerns |
|
|
|
|
Written by Bryan Scribner
|
|
Friday, 07 March 2008 |
As consumer uncertainties manifest over the potential dangers of prescription drugs, the U.S. Food and Drug Administration has pledged to increase communications about newfound side effects of pharmaceuticals.
In a mid-February Wall Street Journal Online/Harris Interactive poll, 79 percent of adults surveyed said they were very or somewhat concerned about the potential side effects of prescription pain medications.
In addition, 82 percent of consumers were very or somewhat concerned about potentially harmful interactions between prescription pain medications and other prescriptions. Seventy percent were very or somewhat concerned over the risk of addiction posed by some prescription pain medications, according to a story in the Journal.
About 10 days after the poll was conducted, another story in the Journal explained that the FDA plans to issue more advisories and warnings about potential drug side effects. The FDA now plans to take a more proactive approach to informing doctors and the public, where in the past it would make announcements only when it was “fairly certain” that the problem was connected to a product.
Systemic enzyme supplements – some of which can provide support for joint pain, headaches or soft tissue injuries – offer a safe alternative to prescription and over-the-counter medications, including nonsteroidal anti-inflammatory drugs.
|
|
Last Updated ( Friday, 07 March 2008 )
|
News 
